ARCHIVES

Richard Klausner resigned from the Gates Foundation, saying move was unrelated to Congressional investigation of NCI contract to Harvard University during Klausner’s tenure as NCI director.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

Cancer Vaccine RFAs Approved In Concept By NCI Advisors

July 26, 1991

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005

In Brief: Edwards Takes A Parting Shot At Cancer Program; “Forward Plan” Calls For Emphasis On Prevention

January 17, 1975

Studies Test New Agents Offering Relief From Treatment-Related Side Effects

July 30, 2004

Cooperative Group Reorganization To Be Offered By DeVita At Clinical Trials Review Next March

October 20, 1978

Also in this 8-page issue: NIH opens 240-bed Hatfield Clinical Research Center.

September 24, 2004